SIMPSON, E. .; YOSIPOVITCH, G. .; EYERICH, K. .; STAUMONT-SALLÉ, D. .; SHAHRIARI, M. .; GALLO, G. .; WOLF, E. .; PIERCE, E. .; LIU, C. .; ZHONG, J. .; AGELL, H. .; DE BRUIN-WELLER, M. . Lebrikizumab Provides Rapid Response in EASI Components and Itch in Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 6, p. s279, 2023. DOI: 10.25251/skin.7.supp.279. Disponível em: https://jofskin.org/index.php/skin/article/view/2389. Acesso em: 3 jul. 2024.